[PHARMA] QoQ Quarter Result on 31-Dec-2016 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Feb-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Dec-2016 [#4]
Profit Trend
QoQ- -106.4%
YoY- -105.2%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 574,503 517,967 618,294 582,816 515,215 531,796 559,195 1.81%
PBT 15,271 10,150 27,777 4,069 19,923 21,487 26,538 -30.79%
Tax -11,381 -399 -8,519 -4,969 -7,275 -5,846 -8,068 25.75%
NP 3,890 9,751 19,258 -900 12,648 15,641 18,470 -64.56%
-
NP to SH 3,580 9,520 18,923 -836 13,061 14,995 18,379 -66.36%
-
Tax Rate 74.53% 3.93% 30.67% 122.12% 36.52% 27.21% 30.40% -
Total Cost 570,613 508,216 599,036 583,716 502,567 516,155 540,725 3.64%
-
Net Worth 531,892 542,147 544,360 531,169 531,250 524,177 515,906 2.05%
Dividend
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Div 12,973 10,376 10,368 7,773 10,365 12,949 10,354 16.20%
Div Payout % 362.37% 108.99% 54.79% 0.00% 79.37% 86.36% 56.34% -
Equity
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Net Worth 531,892 542,147 544,360 531,169 531,250 524,177 515,906 2.05%
NOSH 259,821 259,400 259,219 259,377 259,146 258,981 258,859 0.24%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin 0.68% 1.88% 3.11% -0.15% 2.45% 2.94% 3.30% -
ROE 0.67% 1.76% 3.48% -0.16% 2.46% 2.86% 3.56% -
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
RPS 221.42 199.68 238.52 224.93 198.81 205.34 216.02 1.65%
EPS 1.38 3.67 7.30 -0.32 5.04 5.79 7.10 -66.41%
DPS 5.00 4.00 4.00 3.00 4.00 5.00 4.00 16.02%
NAPS 2.05 2.09 2.10 2.05 2.05 2.024 1.993 1.89%
Adjusted Per Share Value based on latest NOSH - 259,377
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
RPS 39.86 35.94 42.90 40.44 35.75 36.90 38.80 1.81%
EPS 0.25 0.66 1.31 -0.06 0.91 1.04 1.28 -66.30%
DPS 0.90 0.72 0.72 0.54 0.72 0.90 0.72 16.02%
NAPS 0.369 0.3762 0.3777 0.3685 0.3686 0.3637 0.358 2.03%
Price Multiplier on Financial Quarter End Date
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Date 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 -
Price 4.14 4.58 4.89 5.30 5.58 5.50 5.76 -
P/RPS 1.87 2.29 2.05 2.36 2.81 2.68 2.67 -21.11%
P/EPS 300.05 124.80 66.99 -1,642.66 110.71 94.99 81.13 138.96%
EY 0.33 0.80 1.49 -0.06 0.90 1.05 1.23 -58.36%
DY 1.21 0.87 0.82 0.57 0.72 0.91 0.69 45.37%
P/NAPS 2.02 2.19 2.33 2.59 2.72 2.72 2.89 -21.22%
Price Multiplier on Announcement Date
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Date 15/11/17 16/08/17 16/05/17 21/02/17 21/11/16 19/08/16 13/05/16 -
Price 3.82 4.19 4.72 5.12 5.70 5.62 5.60 -
P/RPS 1.73 2.10 1.98 2.28 2.87 2.74 2.59 -23.56%
P/EPS 276.85 114.17 64.66 -1,586.88 113.10 97.06 78.87 130.79%
EY 0.36 0.88 1.55 -0.06 0.88 1.03 1.27 -56.81%
DY 1.31 0.95 0.85 0.59 0.70 0.89 0.71 50.37%
P/NAPS 1.86 2.00 2.25 2.50 2.78 2.78 2.81 -24.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment